ASLAN Pharmaceuticals Limited(NASDAQ:ASLN) 
ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatit...
Website: http://www.aslanpharma.com
Founded: 2010
IPO Price: $8.05 (Dec 03, 2019)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-02-16
P
O 0.56
H 0.56
L 0.50
C 0.52
V 223,508
10EMA 0.52
20EMA 0.52
60EMA 0.52
120EMA 0.52
250EMA 0.52